Back to search

Article

Post-trial access practices in conducted clinical trials for Malaria, Tuberculosis, and Neglected Tropical Diseases (NTDs) across Sub-Saharan African countries:  A quantitative study

2025-11-11

Abstract excerpt

<h4>Background: </h4> According to the Council of International Organizations and Medical Sciences (CIOMS) 2016, post-trial access (PTA) means ensuring that communities involved in research can benefit from the treatments, products, and knowledge developed during the study. Although laws and policies on PTA are still limited, the topic has recently gained attention as part of efforts to promote fair benefit sharin...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
8ef3c3bb-5970-596e-84bb-c22947e1d5f2
DOI
10.12688/openreseurope.18175.5
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Post-trial access practices in conducted clinical trials for Malaria, Tuberculosis, and Neglected Tropical Diseases (NTDs) across Sub-Saharan African countries: A quantitative studyDOI 10.12688/openreseurope.18175.5
Assessing the adoption and impact of decentralized clinical trial approaches in Africa: a multi-country surveySemantic proximity
The TB vaccine clinical trial centre directory: an inventory of clinical trial centres in sub-Saharan AfricaSemantic proximity
Public Knowledge and Attitudes towards Clinical Trial Participation: A Mixed-Method Study in Pwani Region, TanzaniaSemantic proximity
Mixed methods implementation research of oral antiviral treatment for COVID-19 in low and middle-income countries: a study protocolSemantic proximity
Reporting of socio-demographic characteristics of trial participants in infectious diseases clinical trials – a systematic reviewSemantic proximity
Enhancing global clinical trial transparency for better health outcomes for allSemantic proximity
Enhancing global clinical trial transparency for better health outcomes for allSemantic proximity
Community restitution of trial findings in humanitarian settings: a two-stage cascade feedback mechanism and lessons learned from the MAM’Out cash transfer RCT in Burkina FasoSemantic proximity
Impact of SARS-Cov-2 on Clinical Trial Unit Staff: The EPIC Observational StudySemantic proximity
Success Rates and Timelines of African-Inclusive Phase III Trials: A Retrospective AnalysisSemantic proximity
FROM PRIORITIZATION TO ACCESS: DECISION PATHWAYS FOR ESSENTIAL HEALTH TECHNOLOGIES IN SOUTH AFRICA’S PUBLIC SECTORSemantic proximity
Explanatory Modelling of Tuberculosis Treatment Outcomes: The Role of Community Engagement and Clinical GovernanceSemantic proximity
Select a neighboring publication to make it the new centre.